UNC5A and prostate adenocarcinoma: Finally, we evaluated the PFS of patients with or without UNC5A alterations across cancer types, and the results exhibited that patients with UNC5A alterations had a poor PFS in HNSC (p = 0.0127) and PRAD (p = 9.596 × 10−3) (Figure 6D,E).